The European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) reviewed, on 23 October, early data from clinical studies for the three authorised H1N1 flu pandemic vaccines, Celvapan, Focetria and Pandemrix. The...
Identification
Bonjour, l'accès à cet article est réservé aux abonnés. Veuillez vous identifier dans le cadre ci-dessous.
Brazilian beef: Ombudsman faults Commission for late reaction - 22/07/2010
EU reiterates commitment to combating AIDS - 20/07/2010
'Blue mozzarella' problem resolved - 19/07/2010
Avandia: EMEA opinion due by October - 15/07/2010
Platform against obesity: Goals and achievements after five years - 14/07/2010
Millipore-Merck merger approved - 09/07/2010
Regulation headed for conciliation due to stalemate on cloning - 08/07/2010
Brazilian beef: Ombudsman faults Commission for late reaction - 
